Main Menu

Publications Highlights View all by category

Types of Publications


Journal Articles

Lan, L. Evan, T. Li, H. Hussain, A. Ruiz, E.J. Zaw Thin, M. Ferreira, R.M. Ps, H. Riising, E.M. Zen, Y. Almagro, J. Ng, K.W. Soro-Barrio, P. Nelson, J. Koifman, G. Carvalho, J. Nye, E.L. He, Y. Zhang, C. Sadanandam, A. Behrens, A. (2022). GREM1 is required to maintain cellular heterogeneity in pancreatic cancer. Nature, Vol.607 (7917), pp. 163-168.

Khaliq, A.M. Erdogan, C. Kurt, Z. Turgut, S.S. Grunvald, M.W. Rand, T. Khare, S. Borgia, J.A. Hayden, D.M. Pappas, S.G. Govekar, H.R. Kam, A.E. Reiser, J. Turaga, K. Radovich, M. Zang, Y. Qiu, Y. Liu, Y. Fishel, M.L. Turk, A. Gupta, V. Al-Sabti, R. Subramanian, J. Kuzel, T.M. Sadanandam, A. Waldron, L. Hussain, A. Saleem, M. El-Rayes, B. Salahudeen, A.A. Masood, A. (2022). Refining colorectal cancer classification and clinical stratification through a single-cell atlas. , Vol.23 (1), p. 113.  show abstract

Korlimarla, A. PS, H. Prabhu, J. Ragulan, C. Patil, Y. VP, S. Desai, K. Mathews, A. Appachu, S. Diwakar, R.B. BS, S. Melcher, A. Cheang, M. Sadanandam, A. (2022). Comprehensive characterization of immune landscape of Indian and Western triple negative breast cancers. Translational oncology, Vol.25, pp. 101511-101511.

Mooz, J. Riegel, K. Ps, H. Sadanandam, A. Marini, F. Klein, M. Werner, U. Roth, W. Wilken-Schmitz, A. Tegeder, I. Rajalingam, K. (2022). ARAF suppresses ERBB3 expression and metastasis in a subset of lung cancers. Science advances, Vol.8 (11), pp. eabk1538-?.  show abstract

Lakis, V. Lawlor, R.T. Newell, F. Patch, A.-. Mafficini, A. Sadanandam, A. Koufariotis, L.T. Johnston, R.L. Leonard, C. Wood, S. Rusev, B. Corbo, V. Luchini, C. Cingarlini, S. Landoni, L. Salvia, R. Milella, M. Chang, D. Bailey, P. Jamieson, N.B. Duthie, F. Gingras, M.-. Muzny, D.M. Wheeler, D.A. Gibbs, R.A. Milione, M. APGI, ARC-Net, Pederzoli, P. Samra, J.S. Gill, A.J. Johns, A.L. Pearson, J.V. Biankin, A.V. Grimmond, S.M. Waddell, N. Nones, K. Scarpa, A. (2021). DNA methylation patterns identify subgroups of pancreatic neuroendocrine tumors with clinical association. Communications biology, Vol.4 (1), pp. 155-?.  show abstract

Borelli, B. Fontana, E. Giordano, M. Antoniotti, C. Lonardi, S. Bergamo, F. Pietrantonio, F. Morano, F. Tamburini, E. Boccaccino, A. Santini, D. Zucchelli, G. Pella, N. Maiello, E. Passardi, A. Zaniboni, A. Ugolini, C. Fontanini, G. Falcone, A. Nyamundanda, G. Sadanandam, A. Cremolini, C. (2021). Prognostic and predictive impact of consensus molecular subtypes and CRCAssigner classifications in metastatic colorectal cancer: a translational analysis of the TRIBE2 study. Esmo open, Vol.6 (2), pp. 100073-?.  show abstract

Mangal, N. Erridge, S. Habib, N. Sadanandam, A. Reebye, V. Sodergren, M.H. (2021). Cannabinoids in the landscape of cancer. , Vol.147 (9), pp. 2507-2534.  show abstract

Carotenuto, P. Amato, F. Lampis, A. Rae, C. Hedayat, S. Previdi, M.C. Zito, D. Raj, M. Guzzardo, V. Sclafani, F. Lanese, A. Parisi, C. Vicentini, C. Said-Huntingford, I. Hahne, J.C. Hallsworth, A. Kirkin, V. Young, K. Begum, R. Wotherspoon, A. Kouvelakis, K. Azevedo, S.X. Michalarea, V. Upstill-Goddard, R. Rao, S. Watkins, D. Starling, N. Sadanandam, A. Chang, D.K. Biankin, A.V. Jamieson, N.B. Scarpa, A. Cunningham, D. Chau, I. Workman, P. Fassan, M. Valeri, N. Braconi, C. (2021). Modulation of pancreatic cancer cell sensitivity to FOLFIRINOX through microRNA-mediated regulation of DNA damage. Nat commun, Vol.12 (1), pp. 6738-?.  show abstract

Fontana, E. Nyamundanda, G. Cunningham, D. Tu, D. Cheang, M.C. Jonker, D.J. Siu, L.L. Sclafani, F. Eason, K. Ragulan, C. Bali, M.A. Hulkki-Wilson, S. Loree, J.M. Waring, P.M. Giordano, M. Lawrence, P. Rodrigues, D.N. Begum, R. Shapiro, J.D. Price, T.J. Cremolini, C. Starling, N. Pietrantonio, F. Trusolino, L. O'Callaghan, C.J. Sadanandam, A. (2020). Intratumoral Transcriptome Heterogeneity Is Associated With Patient Prognosis and Sidedness in Patients With Colorectal Cancer Treated With Anti-EGFR Therapy From the CO 20 Trial. Jco precision oncology, Vol.4.  show abstract

Young, K. Lawlor, R.T. Ragulan, C. Patil, Y. Mafficini, A. Bersani, S. Antonello, D. Mansfield, D. Cingarlini, S. Landoni, L. Pea, A. Luchini, C. Piredda, L. Kannan, N. Nyamundanda, G. Morganstein, D. Chau, I. Wiedenmann, B. Milella, M. Melcher, A. Cunningham, D. Starling, N. Scarpa, A. Sadanandam, A. (2020). Immune landscape, evolution, hypoxia-mediated viral mimicry pathways and therapeutic potential in molecular subtypes of pancreatic neuroendocrine tumours. Gut, .  show abstract

Young, K. Starling, N. Sadanandam, A. (2020). The molecular biology of pancreatic neuroendocrine neoplasms: Challenges and translational opportunities. Seminars in cancer biology, Vol.61, pp. 132-138.

Sadanandam, A. Bopp, T. Dixit, S. Knapp, D.J. Emperumal, C.P. Vergidis, P. Rajalingam, K. Melcher, A. Kannan, N. (2020). A blood transcriptome-based analysis of disease progression, immune regulation, and symptoms in coronavirus-infected patients. Cell death discovery, Vol.6 (1), pp. 141-?.  show abstract

Tarazona, N. Gimeno-Valiente, F. Gambardella, V. Huerta, M. Roselló, S. Zuniga, S. Calon, A. Carbonell-Asins, J.A. Fontana, E. Martinez-Ciarpaglini, C. Eason, K. Rentero-Garrido, P. Fleitas, T. Papaccio, F. Moro-Valdezate, D. Nyamundanda, G. Castillo, J. Espí, A. Sadanandam, A. Roda, D. Cervantes, A. (2020). Detection of postoperative plasma circulating tumour DNA and lack of CDX2 expression as markers of recurrence in patients with localised colon cancer. Esmo open, Vol.5 (5).  show abstract

Sodergren, M.H. Mangal, N. Wasan, H. Sadanandam, A. Balachandran, V.P. Jiao, L.R. Habib, N. (2020). Immunological combination treatment holds the key to improving survival in pancreatic cancer. Journal of cancer research and clinical oncology, Vol.146 (11), pp. 2897-2911.  show abstract

Nyamundanda, G. Eason, K. Guinney, J. Lord, C.J. Sadanandam, A. (2020). A Machine-Learning Tool Concurrently Models Single Omics and Phenome Data for Functional Subtyping and Personalized Cancer Medicine. Cancers, Vol.12 (10).  show abstract

Cremolini, C. Benelli, M. Fontana, E. Pagani, F. Rossini, D. Fucà, G. Busico, A. Conca, E. Di Donato, S. Loupakis, F. Schirripa, M. Lonardi, S. Borelli, B. Ongaro, E. Eason, K. Morano, F. Casagrande, M. Fassan, M. Sadanandam, A. de Braud, F. Falcone, A. Pietrantonio, F. (2019). Benefit from anti-EGFRs in RAS and BRAF wild-type metastatic transverse colon cancer: a clinical and molecular proof of concept study. Esmo open, Vol.4 (2), pp. e000489-?.  show abstract

Poudel, P. Nyamundanda, G. Patil, Y. Cheang, M.C. Sadanandam, A. (2019). Heterocellular gene signatures reveal luminal-A breast cancer heterogeneity and differential therapeutic responses. Npj breast cancer, Vol.5, pp. 21-?.  show abstract

Wagner, S. Vlachogiannis, G. De Haven Brandon, A. Valenti, M. Box, G. Jenkins, L. Mancusi, C. Self, A. Manodoro, F. Assiotis, I. Robinson, P. Chauhan, R. Rust, A.G. Matthews, N. Eason, K. Khan, K. Starling, N. Cunningham, D. Sadanandam, A. Isacke, C.M. Kirkin, V. Valeri, N. Whittaker, S.R. (2019). Suppression of interferon gene expression overcomes resistance to MEK inhibition in KRAS-mutant colorectal cancer. Oncogene, Vol.38 (10), pp. 1717-1733.  show abstract

Fontana, E. Eason, K. Cervantes, A. Salazar, R. Sadanandam, A. (2019). Context matters-consensus molecular subtypes of colorectal cancer as biomarkers for clinical trials. Annals of oncology : official journal of the european society for medical oncology, Vol.30 (4), pp. 520-527.  show abstract

Neuzillet, C. Tijeras-Raballand, A. Ragulan, C. Cros, J. Patil, Y. Martinet, M. Erkan, M. Kleeff, J. Wilson, J. Apte, M. Tosolini, M. Wilson, A.S. Delvecchio, F.R. Bousquet, C. Paradis, V. Hammel, P. Sadanandam, A. Kocher, H.M. (2019). Inter- and intra-tumoural heterogeneity in cancer-associated fibroblasts of human pancreatic ductal adenocarcinoma. The journal of pathology, Vol.248 (1), pp. 51-65.  show abstract

Dillon, M.T. Bergerhoff, K.F. Pedersen, M. Whittock, H. Crespo-Rodriguez, E. Patin, E.C. Pearson, A. Smith, H.G. Paget, J.T. Patel, R.R. Foo, S. Bozhanova, G. Ragulan, C. Fontana, E. Desai, K. Wilkins, A.C. Sadanandam, A. Melcher, A. McLaughlin, M. Harrington, K.J. (2019). ATR Inhibition Potentiates the Radiation-induced Inflammatory Tumor Microenvironment. Clinical cancer research : an official journal of the american association for cancer research, Vol.25 (11), pp. 3392-3403.  show abstract

Woolston, A. Khan, K. Spain, G. Barber, L.J. Griffiths, B. Gonzalez-Exposito, R. Hornsteiner, L. Punta, M. Patil, Y. Newey, A. Mansukhani, S. Davies, M.N. Furness, A. Sclafani, F. Peckitt, C. Jiménez, M. Kouvelakis, K. Ranftl, R. Begum, R. Rana, I. Thomas, J. Bryant, A. Quezada, S. Wotherspoon, A. Khan, N. Fotiadis, N. Marafioti, T. Powles, T. Lise, S. Calvo, F. Guettler, S. von Loga, K. Rao, S. Watkins, D. Starling, N. Chau, I. Sadanandam, A. Cunningham, D. Gerlinger, M. (2019). Genomic and Transcriptomic Determinants of Therapy Resistance and Immune Landscape Evolution during Anti-EGFR Treatment in Colorectal Cancer. Cancer cell, Vol.36 (1), pp. 35-50.e9.  show abstract

Nyamundanda, G. Fontana, E. Sadanandam, A. (2019). Is the tumour microenvironment a critical prognostic factor in early-stage colorectal cancer?. Annals of oncology : official journal of the european society for medical oncology, Vol.30 (10), pp. 1538-1540.

Ragulan, C. Eason, K. Fontana, E. Nyamundanda, G. Tarazona, N. Patil, Y. Poudel, P. Lawlor, R.T. Del Rio, M. Koo, S.-. Tan, W.-. Sclafani, F. Begum, R. Teixeira Mendes, L.S. Martineau, P. Scarpa, A. Cervantes, A. Tan, I.B. Cunningham, D. Sadanandam, A. (2019). Analytical Validation of Multiplex Biomarker Assay to Stratify Colorectal Cancer into Molecular Subtypes. Scientific reports, Vol.9 (1), pp. 7665-?.  show abstract

Vlachogiannis, G. Hedayat, S. Vatsiou, A. Jamin, Y. Fernández-Mateos, J. Khan, K. Lampis, A. Eason, K. Huntingford, I. Burke, R. Rata, M. Koh, D.-. Tunariu, N. Collins, D. Hulkki-Wilson, S. Ragulan, C. Spiteri, I. Moorcraft, S.Y. Chau, I. Rao, S. Watkins, D. Fotiadis, N. Bali, M. Darvish-Damavandi, M. Lote, H. Eltahir, Z. Smyth, E.C. Begum, R. Clarke, P.A. Hahne, J.C. Dowsett, M. de Bono, J. Workman, P. Sadanandam, A. Fassan, M. Sansom, O.J. Eccles, S. Starling, N. Braconi, C. Sottoriva, A. Robinson, S.P. Cunningham, D. Valeri, N. (2018). Patient-derived organoids model treatment response of metastatic gastrointestinal cancers. Science (new york, n.y.), Vol.359 (6378), pp. 920-926.  show abstract

Smyth, E.C. Nyamundanda, G. Cunningham, D. Fontana, E. Ragulan, C. Tan, I.B. Lin, S.J. Wotherspoon, A. Nankivell, M. Fassan, M. Lampis, A. Hahne, J.C. Davies, A.R. Lagergren, J. Gossage, J.A. Maisey, N. Green, M. Zylstra, J.L. Allum, W.H. Langley, R.E. Tan, P. Valeri, N. Sadanandam, A. (2018). A seven-Gene Signature assay improves prognostic risk stratification of perioperative chemotherapy treated gastroesophageal cancer patients from the MAGIC trial. Annals of oncology : official journal of the european society for medical oncology, Vol.29 (12), pp. 2356-2362.  show abstract

Heindl, A. Khan, A.M. Rodrigues, D.N. Eason, K. Sadanandam, A. Orbegoso, C. Punta, M. Sottoriva, A. Lise, S. Banerjee, S. Yuan, Y. (2018). Microenvironmental niche divergence shapes BRCA1-dysregulated ovarian cancer morphological plasticity. Nature communications, Vol.9 (1), pp. 3917-?.  show abstract

Eason, K. Nyamundanda, G. Sadanandam, A. (2018). polyClustR: defining communities of reconciled cancer subtypes with biological and prognostic significance. Bmc bioinform., Vol.19, pp. 182:1-182:1.

Bijlsma, M.F. Sadanandam, A. Tan, P. Vermeulen, L. (2017). Molecular subtypes in cancers of the gastrointestinal tract. Nature reviews gastroenterology & hepatology, Vol.14 (6), pp. 333-342.

Nyamundanda, G. Poudel, P. Patil, Y. Sadanandam, A. (2017). A Novel Statistical Method to Diagnose, Quantify and Correct Batch Effects in Genomic Studies. Scientific reports, Vol.7 (1), pp. 10849-?.  show abstract

Battersby, N.J. Dattani, M. Rao, S. Cunningham, D. Tait, D. Adams, R. Moran, B.J. Khakoo, S. Tekkis, P. Rasheed, S. Mirnezami, A. Quirke, P. West, N.P. Nagtegaal, I. Chong, I. Sadanandam, A. Valeri, N. Thomas, K. Frost, M. Brown, G. (2017). A rectal cancer feasibility study with an embedded phase III trial design assessing magnetic resonance tumour regression grade (mrTRG) as a novel biomarker to stratify management by good and poor response to chemoradiotherapy (TRIGGER): study protocol for a randomised controlled trial. Trials, Vol.18 (1), pp. 394-?.  show abstract

Eason, K. Sadanandam, A. (2016). Molecular or Metabolic Reprograming: What Triggers Tumor Subtypes?. Cancer research, Vol.76 (18), pp. 5195-5200.  show abstract

Fontana, E. Homicsko, K. Eason, K. Sadanandam, A. (2016). Molecular Classification of Colon Cancer: Perspectives for Personalized Adjuvant Therapy. Current colorectal cancer reports, Vol.12 (6), pp. 296-302.

Guinney, J. Dienstmann, R. Wang, X. de Reyniès, A. Schlicker, A. Soneson, C. Marisa, L. Roepman, P. Nyamundanda, G. Angelino, P. Bot, B.M. Morris, J.S. Simon, I.M. Gerster, S. Fessler, E. De Sousa E Melo, F. Missiaglia, E. Ramay, H. Barras, D. Homicsko, K. Maru, D. Manyam, G.C. Broom, B. Boige, V. Perez-Villamil, B. Laderas, T. Salazar, R. Gray, J.W. Hanahan, D. Tabernero, J. Bernards, R. Friend, S.H. Laurent-Puig, P. Medema, J.P. Sadanandam, A. Wessels, L. Delorenzi, M. Kopetz, S. Vermeulen, L. Tejpar, S. (2015). The consensus molecular subtypes of colorectal cancer. Nature medicine, Vol.21 (11), pp. 1350-1356.

Sadanandam, A. Wullschleger, S. Lyssiotis, C.A. Grötzinger, C. Barbi, S. Bersani, S. Körner, J. Wafy, I. Mafficini, A. Lawlor, R.T. Simbolo, M. Asara, J.M. Bläker, H. Cantley, L.C. Wiedenmann, B. Scarpa, A. Hanahan, D. (2015). A Cross-Species Analysis in Pancreatic Neuroendocrine Tumors Reveals Molecular Subtypes with Distinctive Clinical, Metastatic, Developmental, and Metabolic Characteristics. Cancer discovery, Vol.5 (12), pp. 1296-1313.  show abstract

Kapoor, A. Yao, W. Ying, H. Hua, S. Liewen, A. Wang, Q. Zhong, Y. Wu, C.-. Sadanandam, A. Hu, B. Chang, Q. Chu, G.C. Al-Khalil, R. Jiang, S. Xia, H. Fletcher-Sananikone, E. Lim, C. Horwitz, G.I. Viale, A. Pettazzoni, P. Sanchez, N. Wang, H. Protopopov, A. Zhang, J. Heffernan, T. Johnson, R.L. Chin, L. Wang, Y.A. Draetta, G. DePinho, R.A. (2014). Yap1 activation enables bypass of oncogenic Kras addiction in pancreatic cancer. Cell, Vol.158 (1), pp. 185-197.  show abstract

Bansal, M. Yang, J. Karan, C. Menden, M.P. Costello, J.C. Tang, H. Xiao, G. Li, Y. Allen, J. Zhong, R. Chen, B. Kim, M. Wang, T. Heiser, L.M. Realubit, R. Mattioli, M. Alvarez, M.J. Shen, Y. Gallahan, D. Singer, D. Saez-Rodriguez, J. Xie, Y. Stolovitzky, G. Califano, A. (2014). A community computational challenge to predict the activity of pairs of compounds. Nature biotechnology, Vol.32 (12), pp. 1213-1222.

Costello, J.C. Heiser, L.M. Georgii, E. Gönen, M. Menden, M.P. Wang, N.J. Bansal, M. Ammad-ud-din, M. Hintsanen, P. Khan, S.A. Mpindi, J.-. Kallioniemi, O. Honkela, A. Aittokallio, T. Wennerberg, K. Collins, J.J. Gallahan, D. Singer, D. Saez-Rodriguez, J. Kaski, S. Gray, J.W. Stolovitzky, G. (2014). A community effort to assess and improve drug sensitivity prediction algorithms. Nature biotechnology, Vol.32 (12), pp. 1202-1212.

Purohit, A. Sadanandam, A. Myneni, P. Singh, R.K. (2014). Semaphorin 5A mediated cellular navigation: connecting nervous system and cancer. Biochim biophys acta, Vol.1846 (2), pp. 485-493.  show abstract

Sadanandam, A. Wang, X. de Sousa E Melo, F. Gray, J.W. Vermeulen, L. Hanahan, D. Medema, J.P. (2014). Reconciliation of classification systems defining molecular subtypes of colorectal cancer: interrelationships and clinical implications. Cell cycle, Vol.13 (3), pp. 353-357.  show abstract

Sadanandam, A. Lyssiotis, C.A. Homicsko, K. Collisson, E.A. Gibb, W.J. Wullschleger, S. Ostos, L.C. Lannon, W.A. Grotzinger, C. Del Rio, M. Lhermitte, B. Olshen, A.B. Wiedenmann, B. Cantley, L.C. Gray, J.W. Hanahan, D. (2013). A colorectal cancer classification system that associates cellular phenotype and responses to therapy. Nat med, Vol.19 (5), pp. 619-625.  show abstract

Hunter, K.E. Quick, M.L. Sadanandam, A. Hanahan, D. Joyce, J.A. (2013). Identification and characterization of poorly differentiated invasive carcinomas in a mouse model of pancreatic neuroendocrine tumorigenesis. Plos one, Vol.8 (5), p. e64472.  show abstract

Sadanandam, A. Lal, A. Benz, S.C. Eppenberger-Castori, S. Scott, G. Gray, J.W. Spellman, P. Waldman, F. Benz, C.C. (2012). Genomic aberrations in normal tissue adjacent to HER2-amplified breast cancers: field cancerization or contaminating tumor cells?. Breast cancer res treat, Vol.136 (3), pp. 693-703.  show abstract

Heiser, L.M. Sadanandam, A. Kuo, W.-. Benz, S.C. Goldstein, T.C. Ng, S. Gibb, W.J. Wang, N.J. Ziyad, S. Tong, F. Bayani, N. Hu, Z. Billig, J.I. Dueregger, A. Lewis, S. Jakkula, L. Korkola, J.E. Durinck, S. Pepin, F. Guan, Y. Purdom, E. Neuvial, P. Bengtsson, H. Wood, K.W. Smith, P.G. Vassilev, L.T. Hennessy, B.T. Greshock, J. Bachman, K.E. Hardwicke, M.A. Park, J.W. Marton, L.J. Wolf, D.M. Collisson, E.A. Neve, R.M. Mills, G.B. Speed, T.P. Feiler, H.S. Wooster, R.F. Haussler, D. Stuart, J.M. Gray, J.W. Spellman, P.T. (2012). Subtype and pathway specific responses to anticancer compounds in breast cancer. Proc natl acad sci u s a, Vol.109 (8), pp. 2724-2729.  show abstract

Sadanandam, A. Sidhu, S.S. Wullschleger, S. Singh, S. Varney, M.L. Yang, C.-. Ashour, A.E. Batra, S.K. Singh, R.K. (2012). Secreted semaphorin 5A suppressed pancreatic tumour burden but increased metastasis and endothelial cell proliferation. Br j cancer, Vol.107 (3), pp. 501-507.  show abstract

Collisson, E.A. Sadanandam, A. Olson, P. Gibb, W.J. Truitt, M. Gu, S. Cooc, J. Weinkle, J. Kim, G.E. Jakkula, L. Feiler, H.S. Ko, A.H. Olshen, A.B. Danenberg, K.L. Tempero, M.A. Spellman, P.T. Hanahan, D. Gray, J.W. (2011). Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy. Nat med, Vol.17 (4), pp. 500-503.  show abstract

Sadanandam, A. Futakuchi, M. Lyssiotis, C.A. Gibb, W.J. Singh, R.K. (2011). A cross-species analysis of a mouse model of breast cancer-specific osteolysis and human bone metastases using gene expression profiling. Bmc cancer, Vol.11, p. 304.  show abstract

Sadanandam, A. Varney, M.L. Singh, S. Ashour, A.E. Moniaux, N. Deb, S. Lele, S.M. Batra, S.K. Singh, R.K. (2010). High gene expression of semaphorin 5A in pancreatic cancer is associated with tumor growth, invasion and metastasis. Int j cancer, Vol.127 (6), pp. 1373-1383.  show abstract

Sadanandam, A. Rosenbaugh, E.G. Singh, S. Varney, M. Singh, R.K. (2010). Semaphorin 5A promotes angiogenesis by increasing endothelial cell proliferation, migration, and decreasing apoptosis. Microvasc res, Vol.79 (1), pp. 1-9.  show abstract

Loss, L.A. Sadanandam, A. Durinck, S. Nautiyal, S. Flaucher, D. Carlton, V.E. Moorhead, M. Lu, Y. Gray, J.W. Faham, M. Spellman, P. Parvin, B. (2010). Prediction of epigenetically regulated genes in breast cancer cell lines. Bmc bioinformatics, Vol.11, p. 305.  show abstract

Singh, S. Sadanandam, A. Varney, M.L. Nannuru, K.C. Singh, R.K. (2010). Small interfering RNA-mediated CXCR1 or CXCR2 knock-down inhibits melanoma tumor growth and invasion. Int j cancer, Vol.126 (2), pp. 328-336.  show abstract

Hu, Z. Huang, G. Sadanandam, A. Gu, S. Lenburg, M.E. Pai, M. Bayani, N. Blakely, E.A. Gray, J.W. Mao, J.-. (2010). The expression level of HJURP has an independent prognostic impact and predicts the sensitivity to radiotherapy in breast cancer. Breast cancer res, Vol.12 (2), p. R18.  show abstract

Singh, S. Sadanandam, A. Nannuru, K.C. Varney, M.L. Mayer-Ezell, R. Bond, R. Singh, R.K. (2009). Small-molecule antagonists for CXCR2 and CXCR1 inhibit human melanoma growth by decreasing tumor cell proliferation, survival, and angiogenesis. Clin cancer res, Vol.15 (7), pp. 2380-2386.  show abstract

Futakuchi, M. Nannuru, K.C. Varney, M.L. Sadanandam, A. Nakao, K. Asai, K. Shirai, T. Sato, S.-. Singh, R.K. (2009). Transforming growth factor-beta signaling at the tumor-bone interface promotes mammary tumor growth and osteoclast activation. Cancer sci, Vol.100 (1), pp. 71-81.  show abstract

Singh, S. Nannuru, K. Sadanandam, A. Varney, M. Singh, R. (2009). Expression of CXCR1 and CXCR2 enhances human melanoma tumorigenesis, growth and invasion. Cancer research, Vol.69.

Kuo, W.-. Das, D. Ziyad, S. Bhattacharya, S. Gibb, W.J. Heiser, L.M. Sadanandam, A. Fontenay, G.V. Hu, Z. Wang, N.J. Bayani, N. Feiler, H.S. Neve, R.M. Wyrobek, A.J. Spellman, P.T. Marton, L.J. Gray, J.W. (2009). A systems analysis of the chemosensitivity of breast cancer cells to the polyamine analogue PG-11047. Bmc med, Vol.7, p. 77.  show abstract

Singh, S. Nannuru, K.C. Sadanandam, A. Varney, M.L. Singh, R.K. (2009). CXCR1 and CXCR2 enhances human melanoma tumourigenesis, growth and invasion. Br j cancer, Vol.100 (10), pp. 1638-1646.  show abstract

Nannuru, K.C. Futakuchi, M. Sadanandam, A. Wilson, T.J. Varney, M.L. Myers, K.J. Li, X. Marcusson, E.G. Singh, R.K. (2009). Enhanced expression and shedding of receptor activator of NF-kappaB ligand during tumor-bone interaction potentiates mammary tumor-induced osteolysis. Clin exp metastasis, Vol.26 (7), pp. 797-808.  show abstract

Sadanandam, A. Varney, M.L. Singh, R.K. (2008). Identification of semaphorin 5A interacting protein by applying apriori knowledge and peptide complementarity related to protein evolution and structure. Genomics proteomics bioinformatics, Vol.6 (3-4), pp. 163-174.  show abstract

Wilson, T.J. Nannuru, K.C. Futakuchi, M. Sadanandam, A. Singh, R.K. (2008). Cathepsin G enhances mammary tumor-induced osteolysis by generating soluble receptor activator of nuclear factor-kappaB ligand. Cancer res, Vol.68 (14), pp. 5803-5811.  show abstract

Sadanandam, A. Pal, S.N. Ziskovsky, J. Hegde, P. Singh, R.K. (2008). MCAM: a database to accelerate the identification of functional cell adhesion molecules. Cancer inform, Vol.6, pp. 47-50.  show abstract

Ashour, A.E. Lin, X. Wang, X. Turnquist, H.R. Burns, N.M. Tuli, A. Sadanandam, A. Suleiman, K. Singh, R.K. Talmadge, J.E. Solheim, J.C. (2007). CCL21 is an effective surgical neoadjuvant for treatment of mammary tumors. Cancer biol ther, Vol.6 (8), pp. 1206-1210.  show abstract

Singh, S. Sadanandam, A. Singh, R.K. (2007). Chemokines in tumor angiogenesis and metastasis. Cancer metastasis rev, Vol.26 (3-4), pp. 453-467.  show abstract

Sadanandam, A. Varney, M.L. Kinarsky, L. Ali, H. Mosley, R.L. Singh, R.K. (2007). Identification of functional cell adhesion molecules with a potential role in metastasis by a combination of in vivo phage display and in silico analysis. Omics, Vol.11 (1), pp. 41-57.  show abstract

Sadanandam, A. Sadanandam, A. Collisson, E. Gibb, W. Hanahan, D. Gray, J. Identification of Molecular Subtypes in Pancreatic Adenocarcinoma with Predictive and Prognostic Importance. Protocol exchange, .

Sadanandam, A. Consensus gene expression subtypes of epithelial tumours. Biorxiv (the preprint server for biology), .

Wilkins, A. Fontana, E. Nyamundanda, G. Ragulan, C. Patil, Y. Mansfield, D. Kingston, J. Errington-Mais, F. Bottomley, D. von Loga, K. Bye, H. Carter, P. Tinkler-Hundal, E. Noshirwani, A. Downs, J. Dillon, M. Demaria, S. Sebag-Montefiore, D. Harrington, K. West, N. Melcher, A. Sadanandam, A. Differential and longitudinal immune gene patterns associated with reprogrammed microenvironment and viral mimicry in response to neoadjuvant radiotherapy in rectal cancer. J immunother cancer, Vol.9 (3).  show abstract

Dixit, S. Sadanandam, A. The 2nd Conference and Workshop of The Cancer Genome Atlas (TCGA) in India: Towards Team Science for Multi-omics Cancer Research in South Asia. Ecancermedicalscience, Vol.15.

Angerilli, V. Fontana, E. Lonardi, S. Sbaraglia, M. Borelli, B. Munari, G. Salmaso, R. Guzzardo, V. Spolverato, G. Pucciarelli, S. Pilati, P. Hahne, J.C. Bergamo, F. Zagonel, V. Dei Tos, A.P. Sadanandam, A. Loupakis, F. Valeri, N. Fassan, M. Intratumor morphologic and transcriptomic heterogeneity in V600EBRAF-mutated metastatic colorectal adenocarcinomas. Esmo open, Vol.6 (4), pp. 100211-?.  show abstract


Book Chapters

Collisson, E.A. Sadanandam, A. Spellman, P.T. Gray, J.W. (2009). Cancer genome aberrations: measure, causes, and consequences. In Holland-Frei Cancer Medicine, (Ed.), . Eight (pp. 359-363). BC Decker Publications in collaboration with AACR.

Sadanandam, A. GIbb, W. Singh, R.K. Bioinformatics analysis to identify cell adhesion molecules in cancer. In Preedy, V.R. (Ed.), Modern Insights into Disease from Molecules to Man. Science Publishers.


Conferences

Kapoor, A.Yao, W.Ying, H.Hua, S.Liewen, A.Sadanandam, A.Al-Khalil, R.Viale, A.Pettazzoni, P.Sanchez, N.Protopopov, A.Zhang, J.Heffernan, T.Johnson, R.L.Chin, L.Wang, Y.A.Draetta, G.DePinho, R.A. (2015). Abstract A94: Yap1 activation enables bypass of oncogenic Kras addiction in pancreatic cancer, Cancer Research, Vol.75 (13_Supplement), p.A94.

Darvish Damavandi, M.Braconi, C.Cascione, L.Lampis, A.Hahne, J.Murgia, C.Ghidini, M.Nyamundanda, G.Sadanandam, A.Croce, C.Sansom, O.Valeri, N. (2015). Abstract 3083: Global gene expression profiling of mice tumor-derived organoids identifies key microRNAs and metabolic genes involved in CRC progression, Cancer Research, Vol.75 (15_Supplement), p.3083.

Guinney, J.Dienstmann, R.Wang, X.de Reynies, A.Schlicker, A.Soneson, C.Marisa, L.Roepman, P.Nyamundanda, G.Angelino, P.Bot, B.Morris, J.S.Simon, I.Gerster, S.Fessler, E.de Sousa e Melo, F.Missiaglia, E.Ramay, H.Barras, D.Homicsko, K.Maru, D.Manyam, G.Broom, B.Boige, V.Laderas, T.Salazar, R.Gray, J.W.Tabernero, J.Bernards, R.Friend, S.Laurent-Puig, P.Medema, J.P.Sadanandam, A.Wessels, L.Delorenzi, M.Kopetz, S.Vermeulen, L.Tejpar, S. (2015). Abstract 603: Consensus molecular subtyping through a community of experts advances unsupervised gene expression-based disease classification and facilitates clinical translation, Cancer Research, Vol.75 (15_Supplement), p.603.

Kapoor, A.Yao, W.Ying, H.Hua, S.Liewen, A.Wang, Q.Zhong, Y.Wu, C.-.Sadanandam, A.Hu, B.Chang, Q.Chu, G.Al-Khalil, R.Jiang, S.Xia, H.Fletcher-Sananikone, E.Lim, C.Horwitz, G.Viale, A.Pettazzoni, P.Sanchez, N.Wang, H.Protopopov, A.Zhang, J.Heffernan, T.Johnson, R.Chin, L.Wang, A.Draetta, G.DePinho, R. (2014). Abstract PR01: Yap1 activation enables bypass of oncogenic Kras addiction in pancreatic cancer, Molecular Cancer Research, Vol.12 (12_Supplement), p.PR01.

Homicsko, K.Sadanandam, A. (2014). NEW MOLECULAR CLASSIFICATION OF COLORECTAL CANCER, ANNALS OF ONCOLOGY, Vol.25.

Dienstmann, R.Guinney, J.Delorenzi, M.De Reynies, A.Roepman, P.Sadanandam, A.Vermeulen, L.Schlicker, A.Missiaglia, E.Soneson, C.Marisa, L.Homicsko, K.Wang, X.Simon, I.Laurent-Puig, P.Wessels, L.F.Medema, J.P.Kopetz, S.Friend, S.H.Tejpar, S.Subtyping, C.C. (2014). Colorectal Cancer Subtyping Consortium (CRCSC) identification of a consensus of molecular subtypes., JOURNAL OF CLINICAL ONCOLOGY, Vol.32 (15).

Sadanandam, A.Hanahan, D. (2013). Abstract SY18-02: Molecular genetic subtypes of pancreas and colon cancer: Phenotypes and potential therapeutic significance., Cancer Research, Vol.73 (8_Supplement).

Sadanandam, A.Wullschleger, S.Spellman, P.Hanahan, D.Gray, J.W. (2012). Abstract LB-403: Recurrent fusion transcripts in breast cancer, Cancer Research, Vol.72 (8_Supplement).

Sadanandam, A.Collisson, E.A.Olson, P.Gibb, W.J.Truitt, M.Olshen, A.Tempero, M.A.Spellman, P.T.Hanahan, D.Gray, J.W. (2011). Abstract LB-24: Molecular subtypes of pancreatic adenocarcinoma with different biological characteristics and therapeutical responses, Cancer Research, Vol.71 (8_Supplement).

Sadanandam, A.Gibb, W.Heiser, L.Kuo, W.-.Spellman, P.Gray, J. (2009). Integrated omic analysis of breast cancer cell lines, CANCER RESEARCH, Vol.69.

Sadanandam, A.Varney, M.L.Hollingsworth, M.A.Batra, S.K.Sretavan, D.W.Puschel, A.W.Singh, R.K. (2007). Expression of semaphorin 5A in metastatic pancreatic cancer cells and modulates cellular proliferation, invasion and tumor growth and metastasis, CLINICAL & EXPERIMENTAL METASTASIS, Vol.24 (4), pp.256-257.

Singh, R.Varney, M.Sadanandam, A.Solheim, J.Talmadge, J. (2007). Vascular endothelial growth factor (VEGF)-C and VEGF receptor-3 signaling directly and indirectly modulates murine mammary tumor growth and metastasis, CLINICAL & EXPERIMENTAL METASTASIS, Vol.24 (4), p.232.

Varney, M.L.Sadanandam, A.Solheim, J.C.Talmadge, J.E.Singh, R.K. (2006). VEGFR3 antagonist (MAZ51) directly and indirectly inhibits murine mammary tumor growth and metastasis, CANCER RESEARCH, Vol.66 (8).

Futakuchi, M.Varney, M.L.Sadanandam, A.Nakao, K.Asai, K.Shirai, T.Singh, R.K. (2006). TGF-beta directly and indirectly promote mammary tumor growth in the bone microenvironment by increasing osteoclastgenesis, CANCER RESEARCH, Vol.66 (8).

Sadanandam, A.Varney, M.L.Hollingsworth, M.A.Batra, S.K.Sretavan, D.W.Pueschel, A.W.Singh, R.K. (2006). SEMA5A expression in pancreatic cancer is associated with metastases and regulates pancreatic cancer cell proliferation and their adherence in different microenvironment, CANCER RESEARCH, Vol.66 (8).

Sadanandam, A.Futakuchi, M.Varney, M.Qiu, F.Singh, R. (2006). Gene expression profiling using a unique murine mammary tumor model reveal role of novel genes regulating tumor-stromal interaction in mammary tumor-induced osteolysis, FASEB JOURNAL, Vol.20 (4), p.A222.

Huang, X.Ali, H.H.Sadanandam, A.Singh, R.K. (2005). Protein Motif Searching Through Similar Enriched Parikh Vector Identification., BIBE, , pp.285-289.

Huang, X.Ali, H.H.Sadanandam, A.Singh, R.K. (2004). SRPVS: A New Motif Searching Algorithm for Protein Analysis., CSB, , pp.674-675.

Sadanandam, A.Varney, M.L.Singh, R.K. (2004). High-Throughput Computational and Experimental Biology Strategy in Identifying Tumor Expressing CAMs., CSB, , pp.450-451.